• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血糖诱导的人红细胞醛糖还原酶激活及动力学特性改变。

Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.

作者信息

Srivastava S K, Ansari N H, Hair G A, Jaspan J, Rao M B, Das B

出版信息

Biochim Biophys Acta. 1986 Mar 28;870(2):302-11. doi: 10.1016/0167-4838(86)90234-7.

DOI:10.1016/0167-4838(86)90234-7
PMID:3082363
Abstract

Incubation of human erythrocytes with varying concentrations of glucose resulted in a several-fold increase in aldose reductase (alditol:NADP+ 1-oxidoreductase, EC 1.1.1.21) activity as determined by the rate of NADPH oxidation and the rate of sorbitol formation. As compared to aldose reductase from human erythrocytes not incubated with glucose (native enzyme), aldose reductase from 30 mM glucose-incubated erythrocytes (activated enzyme) exhibited altered kinetic and inhibition properties. Native enzyme showed biphasic kinetics with substrates (glucose and glyceraldehyde), was strongly inhibited by 15 microM ADP, 1,3-diphosphoglycerate, 2,3-diphosphoglycerate and 3-phosphoglycerate, and aldose reductase inhibitors such as sorbinil and alrestatin. The activated enzyme, on the other hand, exhibited monophasic kinetics, low Km for substrates, was not inhibited by the phosphorylated intermediates, and was less susceptible to inhibition by aldose reductase inhibitors. In erythrocytes of the diabetic subjects, we have found an excellent correlation between aldose reductase activity and plasma glucose levels and have observed that whenever the blood glucose level was higher than 15 mM, all of the erythrocyte aldose reductase was present in the activated form and exhibited properties similar to those observed with aldose reductase obtained from 30 mM glucose-incubated erythrocytes.

摘要

用不同浓度的葡萄糖孵育人红细胞,通过NADPH氧化速率和山梨醇生成速率测定发现,醛糖还原酶(醛糖醇:NADP⁺ 1-氧化还原酶,EC 1.1.1.21)活性增加了几倍。与未用葡萄糖孵育的人红细胞中的醛糖还原酶(天然酶)相比,用30 mM葡萄糖孵育的红细胞中的醛糖还原酶(活化酶)表现出改变的动力学和抑制特性。天然酶对底物(葡萄糖和甘油醛)表现出双相动力学,受到15 μM ADP、1,3-二磷酸甘油酸、2,3-二磷酸甘油酸和3-磷酸甘油酸以及醛糖还原酶抑制剂如索比尼尔和阿雷司他汀的强烈抑制。另一方面,活化酶表现出单相动力学,对底物的Km值较低,不受磷酸化中间体的抑制,并且对醛糖还原酶抑制剂的抑制作用较不敏感。在糖尿病患者的红细胞中,我们发现醛糖还原酶活性与血浆葡萄糖水平之间存在极好的相关性,并且观察到每当血糖水平高于15 mM时,所有红细胞醛糖还原酶都以活化形式存在,并且表现出与从用30 mM葡萄糖孵育的红细胞中获得的醛糖还原酶相似的特性。

相似文献

1
Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.高血糖诱导的人红细胞醛糖还原酶激活及动力学特性改变。
Biochim Biophys Acta. 1986 Mar 28;870(2):302-11. doi: 10.1016/0167-4838(86)90234-7.
2
Activated and unactivated forms of human erythrocyte aldose reductase.人红细胞醛糖还原酶的活化形式与非活化形式。
Proc Natl Acad Sci U S A. 1985 Nov;82(21):7222-6. doi: 10.1073/pnas.82.21.7222.
3
Activation of aldose reductase from human tissues.
Diabetes. 1985 Nov;34(11):1145-51. doi: 10.2337/diab.34.11.1145.
4
Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.人红细胞、脑、主动脉、肌肉和眼组织醛糖还原酶的激活。
Metabolism. 1986 Apr;35(4 Suppl 1):114-8. doi: 10.1016/0026-0495(86)90199-x.
5
Activation of aldose reductase by nonenzymatic glycosylation.
Prog Clin Biol Res. 1989;304:171-84.
6
Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.人红细胞中醛糖还原酶和醛还原酶II的纯化及性质
Arch Biochem Biophys. 1985 May 1;238(2):670-9. doi: 10.1016/0003-9861(85)90213-9.
7
Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.醛糖还原酶活性和血糖水平在糖尿病患者红细胞山梨醇蓄积中的关键作用。
Diabetes. 1991 Oct;40(10):1233-40. doi: 10.2337/diab.40.10.1233.
8
Increased erythrocyte aldose reductase activity in type 1 diabetic patients.1型糖尿病患者红细胞醛糖还原酶活性增加。
Diabet Med. 1991 Apr;8(3):226-31. doi: 10.1111/j.1464-5491.1991.tb01577.x.
9
Microdetermination of aldose and aldehyde reductases from human tissues.人体组织中醛糖还原酶和醛还原酶的微量测定。
Curr Eye Res. 1987 Aug;6(8):1001-6. doi: 10.3109/02713688709034871.
10
Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.阿雷司他汀和索比尼尔对人脑海藻糖还原酶和己糖酸脱氢酶的抑制作用。
J Neurochem. 1982 Sep;39(3):810-4. doi: 10.1111/j.1471-4159.1982.tb07964.x.

引用本文的文献

1
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.晚期糖基化终末产物:可改变的环境因素深刻介导胰岛素抵抗。
J Clin Biochem Nutr. 2015 Jul;57(1):1-12. doi: 10.3164/jcbn.15-3. Epub 2015 Jul 1.
2
Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compounds.实验性糖尿病期间肝脏和肾脏代谢途径的调节:抗糖尿病化合物的作用。
Indian J Clin Biochem. 1998 Jul;13(2):63-80. doi: 10.1007/BF02867866.
3
Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.
渗透压和葡萄糖对培养的小鼠足细胞中醛糖还原酶活性有不同的调节作用。
Exp Diabetes Res. 2011;2011:278963. doi: 10.1155/2011/278963. Epub 2011 Dec 29.
4
Mechanisms by which diabetes increases cardiovascular disease.糖尿病增加心血管疾病的机制。
Drug Discov Today Dis Mech. 2007;4(3):131-140. doi: 10.1016/j.ddmec.2007.12.005.
5
Regulation and control of glucose overutilization in erythrocytes by vanadate.钒酸盐对红细胞中葡萄糖过度利用的调节与控制
Mol Cell Biochem. 1995;153(1-2):157-60. doi: 10.1007/BF01075932.
6
The effect of oxidants on biomembranes and cellular metabolism.氧化剂对生物膜及细胞代谢的影响。
Mol Cell Biochem. 1989;91(1-2):149-57. doi: 10.1007/BF00228090.
7
Pharmacological treatment strategies in age-related cataracts.年龄相关性白内障的药物治疗策略
Drugs Aging. 1992 Jul-Aug;2(4):287-300. doi: 10.2165/00002512-199202040-00003.